Intelerad Medical Systems announced that Imagix Medical Imaging, headquartered in Brossard, Quebec, is deploying IntelePACS across their thirteen radiology clinics.
Delaying radiation therapy too long after surgery significantly increases the risk of recurrent tumors in women treated for very early (stage 0) breast cancer, according to new research at Washington University School of Medicine in St. Louis.
Toshiba America Medical Systems Inc.’s Aquilion Lightning computed tomography (CT) system was U.S. Food and Drug Administration (FDA)-cleared with a more powerful 50 kw generator.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
A five-year study shows that stereotactic body radiation therapy (SBRT) offers a higher cure rate for prostate cancer than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.
Elekta, Philips and The Netherlands Cancer Institute, announced the installation of a 1.5 Tesla magnetic resonance (MR)-guided linear accelerator (MR-linac) system.
Delray Medical Center, Delray Beach, Fla., has reached agreement with Proton International (PI) to build a one-room proton therapy treatment center serving the South Florida corridor.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Brainlab AG and Dalhousie University, Atlantic Canada’s leading research-intensive university, have entered into an exclusive intellectual property license agreement for integration with next-generation radiosurgery software.
RefleXion Medical, a medical equipment company developing the first biology-guided radiotherapy system for targeted, personalized cancer treatment, announced that it has closed a $46 million Series B round of funding.
The American College of Radiology (ACR), as a member of a coalition of leading medical societies, provided peripheral arterial disease (PAD) treatment recommendations to the Medicare Evidence Development Coverage Advisory Committee (MEDCAC).
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
With all areas of healthcare now migrating to electronic medical record (EMR) platforms, the data they contain can be ...
As chronic traumatic encephalopathy (CTE) stands in the national spotlight for high impact sports, the University of California, Irvine has partnered with Toshiba America Medical Systems Inc. for a first-of-its-kind study of cerebral microbleeds (CMB) in high school football players as a potential precursor to CTE.
Physicians have begun treating patients with the Mevion S250 proton therapy system at The Marjorie and Leonard Williams Center for Proton Therapy at UF Health Cancer Center-Orlando Health in Florida.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Focal Therapeutics, makers of the three-dimensional BioZorb implant used in breast conservation therapy, announced it has launched BioZorb LP.
The intersection between PET/CT and radiation therapy is widening. And it is doing so in unanticipated ways. You might ...
The global market for contrast media is set to rise from just over $4.3 billion in 2015 to over $6 billion by 2022, according to research and consulting firm GlobalData. This represents a compound annual growth rate of 4.9 percent.
Lung ultrasound has been shown to be highly effective and safe for diagnosing pneumonia in children and a potential substitute for chest X-ray, according to a study conducted at the Icahn School of Medicine at Mount Sinai.
The U.S. Food and Drug Administration (FDA) has received a small number of reports of adverse events that are believed to be associated with computed tomography (CT) imaging of some implantable and wearable electronic devices.
April 13, 2016 — Fujifilm Medical Systems U.S.A. Inc. sponsored the keynote presentation at the National Consortium of ...
Using positron emission tomography (PET) to guide chemotherapy treatment significantly increases the number of people with advanced Hodgkin lymphoma who go into remission, according to new research.
A discussion on the adoption rate of FFR-CT with Campbell Rogers, M.D., chief medical officer of HeartFlow. It is the ...